Business · 29/07/2025Updated: 10/17/2026 · 1 min read
FDA Revokes Emergency Use Authorizations for COVID-19 Treatments
Summary
The FDA has revoked emergency use authorizations for four COVID-19 treatments: REGEN-COV, sotrovimab, bebtelovimab, and EVUSHELD, effective December 13, 2024.
Original source language: Federal Register — Food and Drug AdministrationOpen original release →